Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Clinical trial NCT03985046 · COMPLETED

Trial details

NCT number: NCT03985046
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2019-10-10
Primary completion: 2021-05-31
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.